Cargando…

Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients

This retrospective cohort study investigated the effects of an initially reduced linezolid dosing regimen in hemodialysis patients through therapeutic drug monitoring (TDM). Patients were divided into two groups depending on their initial dose of linezolid (standard dose of 600 mg every 12 h or init...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawasuji, Hitoshi, Tsuji, Yasuhiro, Ogami, Chika, Kaneda, Makito, Murai, Yushi, Kimoto, Kou, Ueno, Akitoshi, Miyajima, Yuki, Fukui, Yasutaka, Sakamaki, Ippei, Yamamoto, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147032/ https://www.ncbi.nlm.nih.gov/pubmed/33925912 http://dx.doi.org/10.3390/antibiotics10050496

Ejemplares similares

Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
por: Kawasuji, Hitoshi, et al.
Publicado: (2021)

A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test
por: Murai, Yushi, et al.
Publicado: (2021)

Investigation of nasopharyngeal viral load at discharge in patients with COVID-19
por: Fukui, Yasutaka, et al.
Publicado: (2021)

Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19
por: Kawasuji, Hitoshi, et al.
Publicado: (2021)

Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
por: Nagaoka, Kentaro, et al.
Publicado: (2022)

Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients
por: Kawasuji, Hitoshi, et al.
Publicado: (2020)

Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity
por: Kawasuji, Hitoshi, et al.
Publicado: (2021)

Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population()
por: Kawasuji, Hitoshi, et al.
Publicado: (2022)

Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection
por: Nagaoka, Kentaro, et al.
Publicado: (2022)

Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population
por: Ueno, Akitoshi, et al.
Publicado: (2021)

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants
por: Nagaoka, Kentaro, et al.
Publicado: (2023)

Mechanism Underlying Linezolid-induced Thrombocytopenia in a Chronic Kidney Failure Mouse Model
por: Nishijo, Nao, et al.
Publicado: (2017)

Monitoring of viral load by RT-PCR caused decision making to continue ECMO therapy for a patient with COVID-19()
por: Sakamaki, Ippei, et al.
Publicado: (2020)

Effects of a rifampicin pre-treatment on linezolid pharmacokinetics
por: Okazaki, Fumiyasu, et al.
Publicado: (2019)

Prostate abscess caused by Nocardia farcina
por: Sakamaki, Ippei, et al.
Publicado: (2019)

Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants
por: Morinaga, Yoshitomo, et al.
Publicado: (2021)

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
por: Tani, Hideki, et al.
Publicado: (2021)

High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant Staphylococcus aureus Bacteremia: An 11-Year Retrospective Study in Japan
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Linezolid vs Vancomycin in Induced Thrombocytopenia
por: Al-Harbi, Dimah, et al.
Publicado: (2022)

Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature
por: Higashi, Yoshitsugu, et al.
Publicado: (2017)

Risk factors for linezolid-associated thrombocytopenia in adult patients
por: Natsumoto, B., et al.
Publicado: (2014)

Risk factors for linezolid-induced thrombocytopenia in adult inpatients
por: Han, Xiaonian, et al.
Publicado: (2021)

Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19
por: Nagaoka, K., et al.
Publicado: (2023)

Effect of linezolid on platelet count in critically ill patients with thrombocytopenia
por: Tatsumi, Hiroomi, et al.
Publicado: (2023)

Effect of Platelet Parameters on Linezolid-Related Thrombocytopenia in Hospitalized Patients
por: Zhang, Lu, et al.
Publicado: (2023)

Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report
por: Xiao, Bing, et al.
Publicado: (2018)

Development of a simple method for measuring tedizolid concentration in human serum using HPLC with a fluorescent detector
por: Tsuji, Yasuhiro, et al.
Publicado: (2021)

Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
por: Brown, Ashley N., et al.
Publicado: (2015)

Predictive values of immune indicators on respiratory failure in the early phase of COVID-19 due to Delta and precedent variants
por: Nagaoka, K., et al.
Publicado: (2023)

Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection
por: Santimaleeworagun, Wichai, et al.
Publicado: (2021)

Nomogram prediction model called “ADPLCP” for predicting linezolid-associated thrombocytopenia in elderly individuals
por: Liu, Yanxin, et al.
Publicado: (2023)

Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia
por: Bi, Li-qing, et al.
Publicado: (2013)

Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients
por: Wang, Jun, et al.
Publicado: (2023)

Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit
por: ZHANG, ZHAORUI, et al.
Publicado: (2014)

Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients
por: Hsu, Yueh-Chun, et al.
Publicado: (2022)

Prevalence and risk factors for severe linezolid-associated thrombocytopenia in pediatric patients: An analysis of a public database
por: Yang, Shibo, et al.
Publicado: (2023)

An Intensified Regimen Containing Linezolid Could Improve Treatment Response in Mycobacterium abscessus Lung Disease
por: Li, Hua, et al.
Publicado: (2019)

Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes
por: Muir, Kathryn B., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a6kvd1bc3je1h1tqbtfc6jpbjt